CLOZAPINE

CLOZAPINE was reported 126474 times

CLOZAPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEUTROPHIL COUNT NORMAL 335 0.9738
1 BENIGN ETHNIC NEUTROPENIA 115 0.8984
2 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 1521 0.8984
3 ANTIPSYCHOTIC DRUG LEVEL DECREASED 426 0.8023
4 ANOSOGNOSIA 498 0.6484
5 REFUSAL OF EXAMINATION 83 0.6336
6 RADIATION INFLAMMATION 50 0.6250
7 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 425 0.6151
8 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1640 0.5820
9 INVESTIGATION NONCOMPLIANCE 58 0.5321
10 BLOOD PROLACTIN ABNORMAL 432 0.5006
11 EOSINOPHIL COUNT DECREASED 1125 0.4721
12 NEUTROPHILIA 2634 0.4626
13 GRANULOCYTOPENIA 2616 0.4588
14 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 400 0.4494
15 NEUTROPHIL COUNT INCREASED 4203 0.4100
16 WITHDRAWAL CATATONIA 94 0.4069
17 SCHIZOPHRENIA 4758 0.3911
18 REBOUND PSYCHOSIS 80 0.3756
19 SCHIZOAFFECTIVE DISORDER 619 0.3468
20 IMMATURE GRANULOCYTE COUNT INCREASED 96 0.3392
21 METAMYELOCYTE COUNT INCREASED 50 0.3356
22 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 69 0.3000
23 DELUSION OF GRANDEUR 121 0.2695
24 MYELOCYTE COUNT INCREASED 47 0.2500
25 PSYCHIATRIC DECOMPENSATION 473 0.2418
26 MEAN CELL HAEMOGLOBIN DECREASED 425 0.2320
27 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 385 0.2307
28 MEAN CELL VOLUME DECREASED 327 0.2119
29 PRE-EXISTING DISEASE 101 0.2078
30 MYOCARDITIS 2283 0.1990
31 DELUSIONAL DISORDER, PERSECUTORY TYPE 82 0.1957
32 LIVING IN RESIDENTIAL INSTITUTION 367 0.1955
33 WRONG PATIENT 96 0.1912
34 SINUS RHYTHM 82 0.1881
35 SALIVARY HYPERSECRETION 1868 0.1865
36 MALIGNANT CATATONIA 49 0.1863
37 DISTURBANCE IN SOCIAL BEHAVIOUR 435 0.1845
38 MONOCYTE COUNT INCREASED 670 0.1843
39 PSYCHOTIC SYMPTOM 380 0.1839
40 SCHIZOPHRENIA, PARANOID TYPE 62 0.1722
41 INTESTINAL PSEUDO-OBSTRUCTION 133 0.1513
42 TROPONIN T INCREASED 192 0.1513
43 MEAN PLATELET VOLUME INCREASED 90 0.1490
44 PLEUROTHOTONUS 127 0.1405
45 NEUTROPENIA 18975 0.1394
46 TROPONIN INCREASED 1033 0.1356
47 CATATONIA 705 0.1341
48 LYMPHOCYTE COUNT INCREASED 438 0.1341
49 BASOPHIL COUNT INCREASED 100 0.1319
50 POSTMORTEM BLOOD DRUG LEVEL INCREASED 49 0.1314
51 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 73 0.1311
52 BLOOD OSMOLARITY INCREASED 43 0.1307
53 DISINHIBITION 200 0.1241
54 IMPRISONMENT 211 0.1193
55 WHITE BLOOD CELL COUNT INCREASED 4541 0.1182
56 MEAN CELL VOLUME INCREASED 301 0.1172
57 RED CELL DISTRIBUTION WIDTH INCREASED 475 0.1142
58 OBSESSIVE-COMPULSIVE SYMPTOM 42 0.1138
59 NEUROLEPTIC MALIGNANT SYNDROME 1335 0.1124
60 AGRANULOCYTOSIS 2087 0.1122
61 QRS AXIS ABNORMAL 86 0.1118
62 MONOCYTE COUNT DECREASED 133 0.1089
63 PSYCHOTIC DISORDER 3167 0.1071
64 MONOCYTOSIS 66 0.1063
65 POLYSEROSITIS 43 0.1009
66 LEUKOCYTOSIS 1800 0.0994
67 STOMA SITE REACTION 68 0.0993
68 PERSECUTORY DELUSION 243 0.0974
69 MENTAL IMPAIRMENT 2345 0.0966
70 BLOOD UREA DECREASED 119 0.0957
71 SUSPICIOUSNESS 67 0.0953
72 GASTROINTESTINAL HYPOMOTILITY 211 0.0935
73 SEDATION 2386 0.0910
74 STOMA SITE IRRITATION 49 0.0901
75 METABOLIC DISORDER 515 0.0886
76 EOSINOPHIL COUNT INCREASED 729 0.0874
77 FAECALOMA 475 0.0866
78 MEGACOLON 136 0.0865
79 ELECTROCARDIOGRAM T WAVE ABNORMAL 134 0.0858
80 METABOLIC SYNDROME 141 0.0858
81 MEAN CELL HAEMOGLOBIN INCREASED 140 0.0845
82 HALLUCINATION, AUDITORY 1334 0.0839
83 HOSPITALISATION 12567 0.0817
84 DELUSIONAL DISORDER, UNSPECIFIED TYPE 61 0.0816
85 WRONG PATIENT RECEIVED PRODUCT 238 0.0813
86 FIBROMA 74 0.0805
87 NEUTROPHIL COUNT DECREASED 3217 0.0789
88 OCULOGYRIC CRISIS 169 0.0787
89 MEAN PLATELET VOLUME DECREASED 66 0.0787
90 PLATELET COUNT INCREASED 994 0.0762
91 STOMA SITE ERYTHEMA 142 0.0759
92 SEDATION COMPLICATION 192 0.0752
93 PSYCHOTIC BEHAVIOUR 76 0.0748
94 BORDERLINE PERSONALITY DISORDER 52 0.0732
95 TROPONIN I INCREASED 121 0.0725
96 COGWHEEL RIGIDITY 75 0.0714
97 ILEUS PARALYTIC 319 0.0714
98 BLOOD BILIRUBIN DECREASED 44 0.0712
99 DELUSION 1089 0.0700
100 NEUTROPHIL COUNT ABNORMAL 198 0.0700
101 ACUTE PSYCHOSIS 172 0.0695
102 LYMPHOCYTE COUNT ABNORMAL 78 0.0693
103 ON AND OFF PHENOMENON 381 0.0686
104 STOMA SITE INFLAMMATION 51 0.0683
105 BODY MASS INDEX INCREASED 92 0.0681
106 INTESTINAL DILATATION 90 0.0675
107 OBSESSIVE-COMPULSIVE DISORDER 530 0.0660
108 REDUCED FACIAL EXPRESSION 66 0.0650
109 ABDOMINAL COMPARTMENT SYNDROME 41 0.0644
110 MYOCARDIAL FIBROSIS 54 0.0643
111 CHOLINERGIC SYNDROME 41 0.0643
112 DRUG LEVEL INCREASED 1059 0.0639
113 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 42 0.0633
114 SINUS TACHYCARDIA 898 0.0632
115 OROMANDIBULAR DYSTONIA 46 0.0631
116 DROOLING 431 0.0623
117 TREATMENT NONCOMPLIANCE 3400 0.0621
118 DEMENTIA WITH LEWY BODIES 69 0.0620
119 HAEMATOCRIT DECREASED 1180 0.0594
120 ECHOCARDIOGRAM ABNORMAL 83 0.0593
121 MUTISM 86 0.0592
122 FREEZING PHENOMENON 219 0.0591
123 SYSTOLIC DYSFUNCTION 62 0.0588
124 STOMA SITE DISCHARGE 159 0.0580
125 PALLIATIVE CARE 85 0.0555
126 PULMONARY VALVE INCOMPETENCE 81 0.0554
127 EOSINOPHILIA 971 0.0554
128 RED BLOOD CELL COUNT INCREASED 150 0.0543
129 LEFT VENTRICULAR HYPERTROPHY 232 0.0542
130 MYOPERICARDITIS 42 0.0538
131 LEUKOPENIA 2696 0.0538
132 ANION GAP INCREASED 72 0.0538
133 ENURESIS 216 0.0534
134 NEUTROPHIL PERCENTAGE INCREASED 67 0.0531
135 TONIC CLONIC MOVEMENTS 69 0.0530
136 LEFT ATRIAL DILATATION 66 0.0517
137 HYPERKINESIA 109 0.0514
138 HAEMOGLOBIN INCREASED 234 0.0512
139 THROMBOCYTOSIS 183 0.0499
140 ELECTROCARDIOGRAM T WAVE INVERSION 110 0.0497
141 THERAPEUTIC PRODUCT EFFECT VARIABLE 193 0.0497
142 C-REACTIVE PROTEIN INCREASED 1797 0.0493
143 LUNG CANCER METASTATIC 142 0.0492
144 LYMPHOCYTE COUNT DECREASED 870 0.0492
145 BLOOD PROLACTIN INCREASED 231 0.0489
146 INTELLECTUAL DISABILITY 74 0.0487
147 SOLILOQUY 42 0.0486
148 ORTHOSTATIC HYPOTENSION 840 0.0482
149 LEFT VENTRICULAR DYSFUNCTION 318 0.0474
150 PERSONALITY CHANGE 436 0.0469
151 DYSTONIA 897 0.0462
152 AKATHISIA 629 0.0461
153 ELECTROENCEPHALOGRAM ABNORMAL 145 0.0459
154 HAEMATOCRIT INCREASED 104 0.0456
155 PARKINSONISM 443 0.0454
156 VOLVULUS 107 0.0451
157 MUSCLE RIGIDITY 537 0.0449
158 APRAXIA 66 0.0445
159 COMA SCALE ABNORMAL 129 0.0445
160 SUBILEUS 92 0.0441
161 PARKINSON'S DISEASE 112 0.0440
162 IMPAIRED SELF-CARE 91 0.0439
163 HIGH DENSITY LIPOPROTEIN DECREASED 146 0.0438
164 PARANOIA 754 0.0437
165 TERMINAL STATE 292 0.0436
166 SEXUAL DYSFUNCTION 511 0.0435
167 ASTERIXIS 46 0.0432
168 ELECTROCARDIOGRAM CHANGE 41 0.0431
169 BUNDLE BRANCH BLOCK RIGHT 198 0.0431
170 GENERAL PHYSICAL CONDITION ABNORMAL 292 0.0430
171 LYMPHOCYTE PERCENTAGE DECREASED 57 0.0424
172 WHITE BLOOD CELL COUNT DECREASED 4532 0.0418
173 WAIST CIRCUMFERENCE INCREASED 43 0.0415
174 PNEUMONIA ASPIRATION 1035 0.0414
175 MYOCLONUS 492 0.0412
176 RED BLOOD CELL COUNT DECREASED 1173 0.0410
177 ELECTROCARDIOGRAM QT PROLONGED 1473 0.0409
178 LYMPHOCYTOSIS 87 0.0404
179 STOMA SITE PAIN 59 0.0401
180 POSTURE ABNORMAL 129 0.0396
181 BLOOD BICARBONATE DECREASED 75 0.0396
182 CONSCIOUSNESS FLUCTUATING 41 0.0393
183 BLOOD SODIUM INCREASED 106 0.0393
184 CARDIOMYOPATHY 578 0.0391
185 ELECTROCARDIOGRAM ABNORMAL 306 0.0390
186 ALCOHOL ABUSE 104 0.0388
187 ASPIRATION 410 0.0374
188 CONGESTIVE CARDIOMYOPATHY 156 0.0374
189 ACCIDENTAL POISONING 51 0.0372
190 BRADYKINESIA 219 0.0371
191 BLOOD CREATINE PHOSPHOKINASE INCREASED 1060 0.0368
192 VENTRICULAR HYPOKINESIA 118 0.0367
193 EMPYEMA 72 0.0362
194 PAROTITIS 41 0.0353
195 APPENDICITIS PERFORATED 89 0.0350
196 GASTROINTESTINAL NECROSIS 102 0.0350
197 POLYDIPSIA 137 0.0346
198 JUDGEMENT IMPAIRED 50 0.0344
199 OBESITY 545 0.0342
200 BEHAVIOUR DISORDER 184 0.0340
201 HYPERPROLACTINAEMIA 219 0.0337
202 BLOOD CHLORIDE INCREASED 58 0.0335
203 DYSLIPIDAEMIA 169 0.0332
204 MENTAL DISORDER 1435 0.0329
205 DYSKINESIA 1340 0.0329
206 DILATATION VENTRICULAR 69 0.0328
207 DRUG DOSE TITRATION NOT PERFORMED 60 0.0327
208 HEAD TITUBATION 45 0.0327
209 LOWER RESPIRATORY TRACT INFECTION 1479 0.0325
210 TACHYCARDIA 2881 0.0324
211 BLOOD CREATININE DECREASED 101 0.0322
212 PSYCHIATRIC SYMPTOM 238 0.0322
213 MYOCLONIC EPILEPSY 48 0.0316
214 DELIRIUM 1098 0.0316
215 NON-HODGKIN'S LYMPHOMA 41 0.0313
216 HAEMOGLOBIN DECREASED 3193 0.0311
217 SUDDEN DEATH 325 0.0307
218 CIRCULATORY COLLAPSE 522 0.0306
219 PSYCHOMOTOR RETARDATION 86 0.0306
220 OBSESSIVE THOUGHTS 55 0.0305
221 REFUSAL OF TREATMENT BY PATIENT 198 0.0303
222 SUBSTANCE USE 47 0.0301
223 STUPOR 96 0.0299
224 ARTERIOSCLEROSIS CORONARY ARTERY 195 0.0294
225 DYSPHEMIA 129 0.0294
226 HALLUCINATIONS, MIXED 123 0.0292
227 INAPPROPRIATE AFFECT 46 0.0290
228 INTESTINAL ISCHAEMIA 158 0.0287
229 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 95 0.0287
230 BRONCHOPNEUMONIA 98 0.0286
231 TORTICOLLIS 60 0.0283
232 ANTICHOLINERGIC SYNDROME 45 0.0282
233 PROTEIN TOTAL DECREASED 106 0.0281
234 CORONAVIRUS INFECTION 186 0.0281
235 PRIAPISM 97 0.0281
236 SOCIAL AVOIDANT BEHAVIOUR 161 0.0278
237 EXTRAPYRAMIDAL DISORDER 684 0.0275
238 LARGE INTESTINAL OBSTRUCTION 61 0.0273
239 VENTRICULAR HYPERTROPHY 67 0.0267
240 CONDUCTION DISORDER 48 0.0262
241 COLITIS ISCHAEMIC 176 0.0261
242 BLOOD PHOSPHORUS INCREASED 71 0.0260
243 PHYSICAL ASSAULT 54 0.0258
244 HYPOTHERMIA 256 0.0253
245 PERSONALITY DISORDER 66 0.0252
246 THERAPY INTERRUPTED 1799 0.0251
247 AGGRESSION 1257 0.0251
248 DIASTOLIC DYSFUNCTION 77 0.0249
249 LUNG ABSCESS 52 0.0248
250 OVERWEIGHT 133 0.0247
251 BUNDLE BRANCH BLOCK LEFT 105 0.0247
252 ALCOHOL POISONING 66 0.0246
253 ILEUS 306 0.0246
254 METASTATIC NEOPLASM 106 0.0245
255 DRUG MONITORING PROCEDURE NOT PERFORMED 44 0.0245
256 SUICIDE ATTEMPT 1483 0.0244
257 PERICARDITIS 410 0.0244
258 FULL BLOOD COUNT ABNORMAL 256 0.0242
259 AKINESIA 50 0.0241
260 HYPERTHERMIA 184 0.0241
261 SMALL INTESTINAL OBSTRUCTION 296 0.0240
262 BLOOD CHLORIDE DECREASED 62 0.0240
263 SERUM FERRITIN DECREASED 41 0.0237
264 BLOOD ALBUMIN DECREASED 187 0.0235
265 GASTROINTESTINAL OBSTRUCTION 56 0.0232
266 BODY TEMPERATURE INCREASED 471 0.0231
267 SUICIDAL BEHAVIOUR 96 0.0231
268 SELF INJURIOUS BEHAVIOUR 70 0.0229
269 MANIA 377 0.0229
270 TRICUSPID VALVE INCOMPETENCE 180 0.0226
271 AUTONOMIC NERVOUS SYSTEM IMBALANCE 66 0.0226
272 WHITE BLOOD CELL DISORDER 60 0.0224
273 BIPOLAR I DISORDER 49 0.0223
274 AFFECTIVE DISORDER 174 0.0221
275 LONG QT SYNDROME 53 0.0221
276 BIPOLAR DISORDER 240 0.0221
277 HEPATITIS C 265 0.0219
278 EUPHORIC MOOD 223 0.0217
279 BLOOD TRIGLYCERIDES INCREASED 384 0.0217
280 DIABETES INSIPIDUS 52 0.0216
281 ABNORMAL BEHAVIOUR 843 0.0213
282 INTENTIONAL SELF-INJURY 427 0.0211
283 PERICARDIAL EFFUSION 487 0.0210
284 SOPOR 279 0.0210
285 EJECTION FRACTION DECREASED 327 0.0210
286 GRAND MAL CONVULSION 192 0.0208
287 BRAIN NATRIURETIC PEPTIDE INCREASED 64 0.0207
288 INTESTINAL OBSTRUCTION 782 0.0207
289 RHINALGIA 57 0.0207
290 STARING 50 0.0207
291 B-CELL LYMPHOMA 70 0.0206
292 GENERALISED TONIC-CLONIC SEIZURE 341 0.0206
293 MITRAL VALVE INCOMPETENCE 232 0.0205
294 VENTRICULAR DYSFUNCTION 53 0.0204
295 TENSION 123 0.0202
296 MICROCYTIC ANAEMIA 42 0.0202
297 DRUG INTERACTION 3202 0.0202
298 HYPERNATRAEMIA 100 0.0200
299 HALLUCINATION, VISUAL 420 0.0199
300 PARADOXICAL DRUG REACTION 73 0.0198
301 IMPULSIVE BEHAVIOUR 73 0.0194
302 FLAT AFFECT 45 0.0194
303 LEUKAEMIA 183 0.0194
304 WRONG PRODUCT ADMINISTERED 131 0.0194
305 TARDIVE DYSKINESIA 545 0.0193
306 APATHY 277 0.0190
307 DIABETIC COMA 53 0.0189
308 SELF-INJURIOUS IDEATION 79 0.0188
309 GAMMA-GLUTAMYLTRANSFERASE INCREASED 417 0.0188
310 AGITATION 1368 0.0186
311 FLUID INTAKE REDUCED 93 0.0186
312 CARDIOMEGALY 226 0.0184
313 REHABILITATION THERAPY 71 0.0183
314 MYOCARDIAL ISCHAEMIA 208 0.0183
315 ACCIDENTAL EXPOSURE 76 0.0182
316 INCOHERENT 118 0.0182
317 PETIT MAL EPILEPSY 93 0.0182
318 INFREQUENT BOWEL MOVEMENTS 45 0.0181
319 HOMICIDAL IDEATION 73 0.0180
320 HALLUCINATION 1356 0.0180
321 THERAPY CESSATION 920 0.0179
322 MENTAL STATUS CHANGES 494 0.0178
323 CHOKING 345 0.0177
324 APPENDICITIS 165 0.0176
325 BLOOD ALKALINE PHOSPHATASE INCREASED 438 0.0176
326 DEMENTIA 490 0.0175
327 TYPE 2 DIABETES MELLITUS 586 0.0174
328 CEREBRAL ATROPHY 69 0.0173
329 UROSEPSIS 159 0.0172
330 OBSTRUCTION 68 0.0170
331 SUDDEN CARDIAC DEATH 58 0.0170
332 LUNG NEOPLASM MALIGNANT 698 0.0170
333 PROTEIN TOTAL INCREASED 45 0.0169
334 LYMPHOMA 261 0.0169
335 HYPOMANIA 62 0.0168
336 SUSPECTED COVID-19 55 0.0167
337 INCONTINENCE 176 0.0166
338 URINARY INCONTINENCE 493 0.0166
339 DRUG LEVEL ABOVE THERAPEUTIC 76 0.0166
340 IRON DEFICIENCY ANAEMIA 153 0.0166
341 DIABETIC COMPLICATION 42 0.0165
342 COMMUNICATION DISORDER 63 0.0165
343 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 857 0.0164
344 THROMBOCYTOPENIA 1826 0.0163
345 DYSARTHRIA 609 0.0162
346 CARDIOPULMONARY FAILURE 63 0.0161
347 UNRESPONSIVE TO STIMULI 417 0.0161
348 POTENTIATING DRUG INTERACTION 54 0.0161
349 DEPRESSIVE SYMPTOM 56 0.0159
350 THINKING ABNORMAL 295 0.0158
351 DEPRESSED LEVEL OF CONSCIOUSNESS 626 0.0158
352 DRUG LEVEL BELOW THERAPEUTIC 87 0.0158
353 FIBRIN D DIMER INCREASED 56 0.0157
354 MULTIPLE DRUG OVERDOSE 78 0.0157
355 BLOOD TEST ABNORMAL 220 0.0156
356 GLOMERULAR FILTRATION RATE DECREASED 192 0.0156
357 DRUG TOXICITY 210 0.0154
358 PULMONARY PAIN 45 0.0154
359 LEFT VENTRICULAR FAILURE 53 0.0154
360 CHRONIC LYMPHOCYTIC LEUKAEMIA 73 0.0154
361 LUNG CONSOLIDATION 43 0.0154
362 PLATELET COUNT DECREASED 1638 0.0154
363 SUBSTANCE ABUSE 125 0.0153
364 BLOOD PHOSPHORUS DECREASED 56 0.0153
365 EPILEPSY 468 0.0153
366 MIOSIS 122 0.0152
367 FAECAL INCONTINENCE 73 0.0152
368 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 58 0.0152
369 ABDOMINAL TENDERNESS 75 0.0151
370 HYPERLIPIDAEMIA 180 0.0150
371 HYPOPHAGIA 377 0.0147
372 RED BLOOD CELL SEDIMENTATION RATE INCREASED 163 0.0147
373 DRUG LEVEL DECREASED 148 0.0145
374 HYPOGAMMAGLOBULINAEMIA 95 0.0144
375 GASTROINTESTINAL CARCINOMA 131 0.0144
376 DEATH 12379 0.0144
377 COMA 680 0.0143
378 IRON DEFICIENCY 64 0.0142
379 RESTLESSNESS 520 0.0142
380 ATRIOVENTRICULAR BLOCK FIRST DEGREE 61 0.0141
381 ANXIETY DISORDER 47 0.0141
382 APPENDICECTOMY 50 0.0140
383 GESTATIONAL DIABETES 66 0.0138
384 EYE MOVEMENT DISORDER 94 0.0137
385 GLUCOSE TOLERANCE IMPAIRED 81 0.0137
386 INCREASED APPETITE 260 0.0136
387 LIVER FUNCTION TEST ABNORMAL 395 0.0136
388 SNORING 51 0.0135
389 AUTISM SPECTRUM DISORDER 74 0.0134
390 BLOOD UREA INCREASED 225 0.0134
391 DYSCHEZIA 41 0.0134
392 SARS-COV-2 TEST POSITIVE 177 0.0134
393 ATAXIA 158 0.0133
394 DIABETES MELLITUS 1009 0.0132
395 BLOOD DISORDER 106 0.0132
396 HYPERTRIGLYCERIDAEMIA 77 0.0131
397 DISORIENTATION 520 0.0131
398 ALTERED STATE OF CONSCIOUSNESS 281 0.0130
399 RHABDOMYOLYSIS 540 0.0129
400 BRAIN INJURY 129 0.0129
401 TYPE 1 DIABETES MELLITUS 77 0.0128
402 LOGORRHOEA 45 0.0128
403 ANKLE FRACTURE 197 0.0127
404 INFLAMMATORY MARKER INCREASED 63 0.0127
405 FOOD POISONING 68 0.0127
406 ISCHAEMIA 58 0.0126
407 COGNITIVE DISORDER 586 0.0125
408 GASTROENTERITIS 182 0.0125
409 BLOOD SODIUM DECREASED 234 0.0124
410 CONFUSIONAL STATE 2000 0.0124
411 VENTRICULAR EXTRASYSTOLES 128 0.0123
412 HEPATIC STEATOSIS 226 0.0121
413 CONVULSION 691 0.0121
414 HYPERPHAGIA 48 0.0120
415 SUICIDAL IDEATION 1099 0.0120
416 CONTRAINDICATED PRODUCT ADMINISTERED 363 0.0120
417 ALCOHOL USE 44 0.0119
418 NEOPLASM MALIGNANT 795 0.0119
419 MAJOR DEPRESSION 87 0.0119
420 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 104 0.0118
421 ASPHYXIA 95 0.0116
422 SOMNOLENCE 2335 0.0116
423 PSYCHOMOTOR HYPERACTIVITY 192 0.0116
424 DIABETIC NEUROPATHY 57 0.0115
425 HYPERPYREXIA 48 0.0113
426 SCREAMING 72 0.0113
427 GASTROINTESTINAL SOUNDS ABNORMAL 56 0.0113
428 CONSTIPATION 2452 0.0112
429 IMMOBILE 49 0.0112
430 PRODUCT DISPENSING ISSUE 48 0.0112
431 TOXICITY TO VARIOUS AGENTS 1892 0.0112
432 SEPSIS 1246 0.0112
433 ALANINE AMINOTRANSFERASE INCREASED 683 0.0111
434 EMPHYSEMA 112 0.0111
435 GENERAL PHYSICAL HEALTH DETERIORATION 1278 0.0110
436 TACHYPNOEA 150 0.0110
437 FEMORAL NECK FRACTURE 56 0.0109
438 NEUTROPENIC SEPSIS 78 0.0109
439 SEROTONIN SYNDROME 209 0.0109
440 TIBIA FRACTURE 51 0.0109
441 AORTIC VALVE INCOMPETENCE 46 0.0108
442 HYPERCHOLESTEROLAEMIA 104 0.0108
443 POISONING 135 0.0107
444 CARDIAC ARREST 876 0.0106
445 BRADYPHRENIA 69 0.0106
446 ALCOHOLISM 45 0.0105
447 DRUG RESISTANCE 270 0.0105
448 BRAIN NEOPLASM 96 0.0104
449 PRODUCT ADMINISTRATION ERROR 210 0.0104
450 EATING DISORDER 221 0.0104
451 RESPIRATORY DEPRESSION 127 0.0104
452 REBOUND EFFECT 117 0.0103
453 ATELECTASIS 100 0.0103
454 HYPOKINESIA 150 0.0103
455 PNEUMONIA 3321 0.0102
456 INTENTIONAL OVERDOSE 657 0.0102
457 MOTOR DYSFUNCTION 104 0.0102
458 CARDIOTOXICITY 91 0.0102
459 LETHARGY 585 0.0102
460 PYELONEPHRITIS 88 0.0101
461 HAEMATEMESIS 257 0.0101
462 RESPIRATORY TRACT INFECTION 264 0.0101
463 POLYURIA 83 0.0101
464 PLEURISY 60 0.0101
465 CARDIAC TAMPONADE 48 0.0101
466 RESPIRATORY FAILURE 736 0.0101
467 SPLENOMEGALY 118 0.0101
468 TRISMUS 52 0.0101
469 GOITRE 41 0.0100
470 DIABETIC KETOACIDOSIS 239 0.0099
471 SEIZURE 1144 0.0099
472 PULMONARY CONGESTION 130 0.0099
473 GALACTORRHOEA 63 0.0098
474 HYPERAMMONAEMIA 49 0.0098
475 VIRAL INFECTION 324 0.0097
476 ANAEMIA 1842 0.0096
477 DECUBITUS ULCER 78 0.0096
478 URINARY TRACT INFECTION 1631 0.0096
479 INTESTINAL PERFORATION 107 0.0095
480 ARTERIOSCLEROSIS 89 0.0094
481 SPEECH DISORDER 495 0.0094
482 CHOLECYSTITIS 112 0.0094
483 COMPLETED SUICIDE 771 0.0092
484 RESPIRATORY RATE INCREASED 82 0.0092
485 BLOOD PRESSURE SYSTOLIC DECREASED 42 0.0092
486 COVID-19 1618 0.0092
487 ENCEPHALOPATHY 226 0.0092
488 HUMERUS FRACTURE 44 0.0091
489 URINARY RETENTION 304 0.0091
490 SERUM FERRITIN INCREASED 48 0.0091
491 HYPERTONIA 52 0.0091
492 POISONING DELIBERATE 86 0.0091
493 OVERDOSE 1946 0.0090
494 TIC 49 0.0090
495 OESOPHAGITIS 98 0.0090
496 RALES 52 0.0089
497 INFECTION 1289 0.0089
498 MALAISE 3900 0.0089
499 MEDICATION ERROR 494 0.0089
500 BLOOD URIC ACID INCREASED 51 0.0088
501 HYPOTONIA 88 0.0088
502 HAEMODYNAMIC INSTABILITY 67 0.0088
503 PRESCRIBED OVERDOSE 170 0.0088
504 HYPOXIA 306 0.0087
505 LOW DENSITY LIPOPROTEIN INCREASED 67 0.0086
506 ACUTE RESPIRATORY FAILURE 166 0.0086
507 BLOOD LACTATE DEHYDROGENASE INCREASED 136 0.0086
508 ENDOCARDITIS 44 0.0086
509 NOCTURIA 104 0.0086
510 HEART RATE INCREASED 846 0.0085
511 BRUXISM 46 0.0085
512 RESPIRATORY DISTRESS 235 0.0085
513 LOSS OF CONSCIOUSNESS 1085 0.0085
514 BLOOD CALCIUM DECREASED 95 0.0084
515 BODY TEMPERATURE DECREASED 83 0.0084
516 DYSPHAGIA 800 0.0084
517 PULMONARY EMBOLISM 792 0.0083
518 FALL 2765 0.0083
519 RESPIRATORY DISORDER 247 0.0082
520 HEAD INJURY 261 0.0082
521 TONSILLITIS 43 0.0082
522 AFFECT LABILITY 79 0.0082
523 LARGE INTESTINE PERFORATION 57 0.0082
524 LYMPHOPENIA 116 0.0082
525 WHITE BLOOD CELL COUNT ABNORMAL 52 0.0081
526 HYPOTENSION 1627 0.0081
527 WEIGHT INCREASED 1816 0.0081
528 HOSPICE CARE 80 0.0081
529 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 41 0.0081
530 BOWEL MOVEMENT IRREGULARITY 62 0.0081
531 THERAPY PARTIAL RESPONDER 126 0.0081
532 SLEEP APNOEA SYNDROME 154 0.0081
533 CELLULITIS 406 0.0080
534 CARDIAC DISORDER 747 0.0080
535 CACHEXIA 41 0.0080
536 LOWER LIMB FRACTURE 152 0.0079
537 WITHDRAWAL SYNDROME 330 0.0079
538 BLOOD CHOLESTEROL INCREASED 366 0.0078
539 METABOLIC ACIDOSIS 250 0.0078
540 CARDIOGENIC SHOCK 112 0.0078
541 MOVEMENT DISORDER 249 0.0077
542 BLOOD THYROID STIMULATING HORMONE INCREASED 71 0.0077
543 RENAL FAILURE CHRONIC 59 0.0077
544 ARRHYTHMIA 361 0.0076
545 HYDRONEPHROSIS 57 0.0076
546 PYREXIA 2633 0.0076
547 HEPATITIS 194 0.0076
548 ATRIAL SEPTAL DEFECT 63 0.0075
549 SEPTIC SHOCK 325 0.0075
550 DIABETES MELLITUS INADEQUATE CONTROL 131 0.0074
551 ATRIAL FLUTTER 59 0.0074
552 CYANOSIS 116 0.0074
553 HYPONATRAEMIA 415 0.0074
554 DISTURBANCE IN ATTENTION 397 0.0074
555 POOR VENOUS ACCESS 76 0.0073
556 LOSS OF LIBIDO 66 0.0073
557 PLEURAL EFFUSION 446 0.0073
558 RESPIRATORY ARREST 201 0.0073
559 MUSCLE TWITCHING 168 0.0073
560 METASTASIS 52 0.0073
561 CARDIAC FAILURE ACUTE 48 0.0072
562 PALLOR 196 0.0072
563 ENTERITIS 46 0.0072
564 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 510 0.0072
565 ACUTE PULMONARY OEDEMA 40 0.0071
566 CARDIO-RESPIRATORY ARREST 295 0.0070
567 HYPERSOMNIA 199 0.0069
568 TREMOR 1131 0.0068
569 MALNUTRITION 76 0.0068
570 SUPRAVENTRICULAR TACHYCARDIA 65 0.0068
571 VITAMIN D DEFICIENCY 66 0.0068
572 STATUS EPILEPTICUS 76 0.0067
573 ABNORMAL FAECES 55 0.0067
574 TOOTH ABSCESS 68 0.0067
575 PRODUCT DISPENSING ERROR 145 0.0067
576 ASPARTATE AMINOTRANSFERASE INCREASED 353 0.0066
577 COLON CANCER 99 0.0066
578 ATRIOVENTRICULAR BLOCK COMPLETE 44 0.0066
579 DRUG ABUSE 545 0.0065
580 BLOOD CREATININE INCREASED 426 0.0065
581 ENCEPHALITIS 45 0.0065
582 MULTIPLE ORGAN DYSFUNCTION SYNDROME 183 0.0065
583 MENINGITIS 43 0.0064
584 APNOEA 50 0.0064
585 POST-TRAUMATIC STRESS DISORDER 43 0.0064
586 DEPRESSED MOOD 339 0.0064
587 HYPERGLYCAEMIA 233 0.0064
588 CARDIAC FAILURE 513 0.0064
589 PULMONARY OEDEMA 285 0.0064
590 TUBULOINTERSTITIAL NEPHRITIS 119 0.0063
591 POOR QUALITY SLEEP 136 0.0063
592 IRRITABILITY 378 0.0063
593 HYPERTHYROIDISM 91 0.0063
594 ELECTROLYTE IMBALANCE 73 0.0063
595 HEPATOCELLULAR INJURY 89 0.0063
596 PANCREATITIS 331 0.0063
597 BREAST CANCER METASTATIC 67 0.0062
598 HIP FRACTURE 198 0.0062
599 ANAL INCONTINENCE 55 0.0061
600 MYOCARDIAL INFARCTION 1064 0.0061
601 CHOLELITHIASIS 200 0.0061
602 INSURANCE ISSUE 93 0.0061
603 PHARYNGITIS 75 0.0060
604 CHEST PAIN 1118 0.0060
605 ABSCESS 96 0.0060
606 IMPAIRED GASTRIC EMPTYING 82 0.0060
607 TORSADE DE POINTES 47 0.0060
608 OXYGEN SATURATION DECREASED 335 0.0060
609 MULTI-ORGAN FAILURE 103 0.0060
610 BRAIN OEDEMA 75 0.0059
611 ACUTE CORONARY SYNDROME 49 0.0059
612 SYNCOPE 591 0.0059
613 PERITONITIS 122 0.0059
614 INFLUENZA LIKE ILLNESS 484 0.0059
615 HYPOTHYROIDISM 186 0.0058
616 THERAPY CHANGE 57 0.0058
617 HYPERHIDROSIS 743 0.0058
618 GLYCOSYLATED HAEMOGLOBIN INCREASED 145 0.0057
619 BLOOD GLUCOSE INCREASED 1061 0.0056
620 HEPATOMEGALY 55 0.0056
621 MOBILITY DECREASED 401 0.0056
622 DIZZINESS POSTURAL 54 0.0056
623 APHASIA 168 0.0056
624 PANCREATITIS ACUTE 125 0.0056
625 OVARIAN CANCER 51 0.0055
626 VITAMIN D DECREASED 47 0.0055
627 HEPATIC CYTOLYSIS 70 0.0055
628 PANCYTOPENIA 305 0.0055
629 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 56 0.0054
630 FRUSTRATION TOLERANCE DECREASED 44 0.0054
631 FRACTURE 103 0.0054
632 CARDIAC MURMUR 47 0.0054
633 METASTASES TO LIVER 95 0.0054
634 UNEVALUABLE EVENT 407 0.0054
635 SHOCK 123 0.0053
636 SINUS BRADYCARDIA 51 0.0053
637 WRONG DRUG ADMINISTERED 47 0.0053
638 METASTASES TO CENTRAL NERVOUS SYSTEM 68 0.0053
639 INITIAL INSOMNIA 54 0.0053
640 THERAPY NON-RESPONDER 236 0.0052
641 BLOOD POTASSIUM DECREASED 157 0.0052
642 LUNG INFILTRATION 46 0.0052
643 INFLAMMATION 267 0.0052
644 ACUTE MYOCARDIAL INFARCTION 151 0.0051
645 FEAR 137 0.0051
646 ACUTE RESPIRATORY DISTRESS SYNDROME 90 0.0051
647 CONDITION AGGRAVATED 1546 0.0051
648 HEPATIC CIRRHOSIS 95 0.0051
649 DEHYDRATION 674 0.0050
650 PNEUMONIA BACTERIAL 46 0.0050
651 ABNORMAL DREAMS 138 0.0050
652 MYDRIASIS 64 0.0050
653 CYTOPENIA 61 0.0050
654 QUALITY OF LIFE DECREASED 66 0.0049
655 SLUGGISHNESS 50 0.0049
656 BLOOD MAGNESIUM DECREASED 42 0.0049
657 ACCIDENTAL OVERDOSE 178 0.0049
658 BLOOD POTASSIUM INCREASED 79 0.0049
659 BLOOD BILIRUBIN INCREASED 131 0.0048
660 GASTROINTESTINAL INFECTION 43 0.0048
661 BLOOD CALCIUM INCREASED 42 0.0048
662 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 230 0.0048
663 METASTASES TO LUNG 55 0.0048
664 RESTLESS LEGS SYNDROME 86 0.0047
665 HYPERCALCAEMIA 58 0.0047
666 ACCIDENT 56 0.0047
667 BLOOD PRESSURE FLUCTUATION 112 0.0047
668 BEDRIDDEN 61 0.0046
669 RENAL FAILURE ACUTE 196 0.0046
670 COORDINATION ABNORMAL 64 0.0046
671 HIATUS HERNIA 59 0.0046
672 ERECTILE DYSFUNCTION 117 0.0046
673 ANXIETY 1296 0.0045
674 HEMIPARESIS 77 0.0045
675 COLITIS 172 0.0045
676 BLOOD COUNT ABNORMAL 68 0.0045
677 HYPERTENSION 949 0.0045
678 BALANCE DISORDER 386 0.0045
679 VOMITING 2087 0.0044
680 BLOOD PRESSURE DECREASED 293 0.0044
681 OFF LABEL USE 3854 0.0044
682 NEPHROPATHY 41 0.0044
683 GAIT DISTURBANCE 840 0.0044
684 TRANSIENT ISCHAEMIC ATTACK 148 0.0044
685 BLOOD IRON DECREASED 52 0.0044
686 CAESAREAN SECTION 51 0.0044
687 ADVERSE DRUG REACTION 393 0.0044
688 LABORATORY TEST ABNORMAL 129 0.0044
689 SLEEP DISORDER 308 0.0044
690 SCRATCH 46 0.0044
691 UPPER RESPIRATORY TRACT INFECTION 200 0.0043
692 POST PROCEDURAL COMPLICATION 83 0.0043
693 SKIN LACERATION 47 0.0043
694 COVID-19 PNEUMONIA 51 0.0043
695 HYPOKALAEMIA 199 0.0043
696 SURGERY 252 0.0043
697 CORONARY ARTERY DISEASE 130 0.0043
698 PRODUCT DOSE OMISSION ISSUE 1262 0.0043
699 ANGER 143 0.0042
700 INTENTIONAL PRODUCT MISUSE 368 0.0042
701 MUSCULOSKELETAL STIFFNESS 368 0.0042
702 ABDOMINAL DISTENSION 437 0.0042
703 GASTROINTESTINAL PAIN 46 0.0042
704 MIDDLE INSOMNIA 78 0.0042
705 BRADYCARDIA 221 0.0042
706 JOINT DISLOCATION 44 0.0042
707 GASTRITIS 109 0.0041
708 SUBARACHNOID HAEMORRHAGE 42 0.0041
709 PARALYSIS 59 0.0041
710 WOUND INFECTION 45 0.0041
711 DECREASED ACTIVITY 44 0.0041
712 COLD SWEAT 71 0.0040
713 RENAL IMPAIRMENT 338 0.0040
714 NO THERAPEUTIC RESPONSE 49 0.0040
715 MEMORY IMPAIRMENT 552 0.0040
716 DRUG INTOLERANCE 388 0.0040
717 ABDOMINAL PAIN 934 0.0040
718 DEEP VEIN THROMBOSIS 259 0.0040
719 THERAPEUTIC RESPONSE DECREASED 241 0.0040
720 PNEUMOTHORAX 63 0.0040
721 INFLUENZA 443 0.0040
722 NO ADVERSE EVENT 717 0.0040
723 DISEASE RECURRENCE 188 0.0039
724 ROAD TRAFFIC ACCIDENT 165 0.0039
725 GASTROENTERITIS VIRAL 71 0.0039
726 DEVICE OCCLUSION 55 0.0039
727 DRUG-INDUCED LIVER INJURY 122 0.0039
728 BONE MARROW FAILURE 79 0.0039
729 OROPHARYNGEAL PAIN 359 0.0039
730 ACUTE KIDNEY INJURY 592 0.0039
731 OBSTRUCTIVE AIRWAYS DISORDER 43 0.0039
732 LUNG INFECTION 60 0.0039
733 HEPATIC FUNCTION ABNORMAL 144 0.0039
734 PRODUCT USE IN UNAPPROVED INDICATION 942 0.0038
735 BLOOD PRESSURE SYSTOLIC INCREASED 74 0.0038
736 UPPER LIMB FRACTURE 75 0.0038
737 HEART RATE IRREGULAR 85 0.0038
738 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 64 0.0037
739 DYSSTASIA 109 0.0037
740 TOOTH INFECTION 49 0.0037
741 AMENORRHOEA 65 0.0037
742 MUCOSAL INFLAMMATION 96 0.0037
743 LUNG DISORDER 179 0.0036
744 ADVERSE EVENT 335 0.0036
745 SUBDURAL HAEMATOMA 52 0.0036
746 WEIGHT DECREASED 1006 0.0036
747 SKIN ULCER 93 0.0036
748 METASTASES TO BONE 59 0.0036
749 RENAL FAILURE 475 0.0036
750 FOETAL EXPOSURE DURING PREGNANCY 290 0.0036
751 KIDNEY INFECTION 70 0.0036
752 BACTERIAL INFECTION 66 0.0035
753 CEREBROVASCULAR ACCIDENT 599 0.0035
754 JAUNDICE 95 0.0035
755 DEPRESSION 793 0.0035
756 TRANSAMINASES INCREASED 77 0.0035
757 BACTERAEMIA 41 0.0035
758 PRODUCT USE ISSUE 648 0.0034
759 PRODUCT PRESCRIBING ERROR 82 0.0034
760 OESOPHAGEAL CARCINOMA 102 0.0034
761 EMOTIONAL DISORDER 106 0.0034
762 CHOLESTASIS 66 0.0034
763 TOOTHACHE 62 0.0034
764 HYPOGLYCAEMIA 166 0.0034
765 LIVER DISORDER 151 0.0034
766 PANIC ATTACK 124 0.0034
767 ANGINA PECTORIS 97 0.0034
768 TREATMENT FAILURE 279 0.0034
769 ACUTE HEPATIC FAILURE 46 0.0034
770 STAPHYLOCOCCAL INFECTION 111 0.0034
771 PULMONARY MASS 50 0.0034
772 PRODUCT DOSE OMISSION 218 0.0033
773 IMMUNODEFICIENCY 49 0.0033
774 CARDIOVASCULAR DISORDER 83 0.0033
775 FEEDING DISORDER 66 0.0033
776 MUSCULOSKELETAL CHEST PAIN 50 0.0032
777 BREAST CANCER 300 0.0032
778 FOOT FRACTURE 61 0.0032
779 PULMONARY HYPERTENSION 67 0.0032
780 NERVOUS SYSTEM DISORDER 100 0.0032
781 PRODUCT PRESCRIBING ISSUE 69 0.0032
782 GASTROINTESTINAL HAEMORRHAGE 264 0.0032
783 THIRST 56 0.0031
784 IMPAIRED QUALITY OF LIFE 45 0.0031
785 ILLNESS 318 0.0031
786 DRUG DISPENSING ERROR 47 0.0031
787 BLOOD PRESSURE ABNORMAL 61 0.0031
788 DRUG INEFFECTIVE 4035 0.0031
789 MALIGNANT MELANOMA 41 0.0031
790 DIZZINESS 1519 0.0030
791 AMNESIA 198 0.0030
792 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 167 0.0030
793 DRUG EFFECT LESS THAN EXPECTED 45 0.0030
794 UPPER GASTROINTESTINAL HAEMORRHAGE 51 0.0030
795 LIVER FUNCTION TEST INCREASED 65 0.0030
796 DYSPNOEA 1707 0.0030
797 CARDIAC FAILURE CONGESTIVE 242 0.0030
798 INSOMNIA 801 0.0030
799 RETCHING 64 0.0030
800 HEPATIC FAILURE 89 0.0029
801 MYELODYSPLASTIC SYNDROME 42 0.0029
802 ATRIAL FIBRILLATION 282 0.0029
803 IRRITABLE BOWEL SYNDROME 62 0.0029
804 MOOD SWINGS 92 0.0029
805 POLLAKIURIA 120 0.0029
806 OSTEOMYELITIS 52 0.0029
807 DEVICE DISLOCATION 124 0.0028
808 BLOOD PRESSURE INCREASED 436 0.0028
809 HEPATIC ENZYME INCREASED 194 0.0028
810 ASTHMA 319 0.0028
811 HAEMORRHOIDS 55 0.0028
812 PALPITATIONS 330 0.0028
813 GAIT INABILITY 94 0.0028
814 ASTHENIA 1042 0.0028
815 DRUG EXPOSURE DURING PREGNANCY 94 0.0028
816 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 71 0.0028
817 MOOD ALTERED 75 0.0027
818 CEREBRAL INFARCTION 67 0.0027
819 HERNIA 53 0.0027
820 LIVER INJURY 67 0.0027
821 HAEMATURIA 93 0.0027
822 PRESYNCOPE 66 0.0027
823 PANCREATIC CARCINOMA 78 0.0027
824 COAGULOPATHY 45 0.0027
825 ACUTE MYELOID LEUKAEMIA 42 0.0027
826 PRODUCTIVE COUGH 128 0.0027
827 MELAENA 59 0.0027
828 PRODUCT AVAILABILITY ISSUE 61 0.0027
829 HIP ARTHROPLASTY 41 0.0027
830 EAR INFECTION 71 0.0027
831 RENAL DISORDER 123 0.0026
832 HEART RATE DECREASED 92 0.0026
833 LYMPHADENOPATHY 92 0.0026
834 DYSURIA 95 0.0026
835 DRUG WITHDRAWAL SYNDROME 225 0.0026
836 DECREASED APPETITE 585 0.0025
837 GASTROOESOPHAGEAL REFLUX DISEASE 202 0.0025
838 INJURY 175 0.0025
839 VENTRICULAR TACHYCARDIA 41 0.0025
840 PHARMACEUTICAL PRODUCT COMPLAINT 63 0.0024
841 MUSCULAR WEAKNESS 273 0.0024
842 CYSTITIS 76 0.0024
843 DRUG ADMINISTRATION ERROR 73 0.0024
844 ACTIVITIES OF DAILY LIVING IMPAIRED 47 0.0024
845 LOCALISED INFECTION 57 0.0024
846 ABASIA 58 0.0023
847 CLOSTRIDIUM DIFFICILE INFECTION 51 0.0023
848 FAECES DISCOLOURED 50 0.0023
849 OEDEMA PERIPHERAL 281 0.0023
850 GASTROINTESTINAL DISORDER 205 0.0023
851 GASTRIC ULCER 43 0.0023
852 COUGH 631 0.0022
853 IMPAIRED WORK ABILITY 48 0.0022
854 ASCITES 66 0.0022
855 FEELING COLD 62 0.0022
856 PNEUMONITIS 60 0.0022
857 JOINT INJURY 47 0.0022
858 EAR PAIN 42 0.0022
859 CHEST DISCOMFORT 220 0.0021
860 KNEE ARTHROPLASTY 45 0.0021
861 GYNAECOMASTIA 66 0.0021
862 ILL-DEFINED DISORDER 129 0.0021
863 HAEMOPTYSIS 59 0.0021
864 MATERNAL EXPOSURE DURING PREGNANCY 186 0.0021
865 WOUND 58 0.0021
866 CHRONIC KIDNEY DISEASE 156 0.0021
867 DIARRHOEA 1324 0.0020
868 THERAPEUTIC RESPONSE SHORTENED 68 0.0020
869 OEDEMA 110 0.0020
870 DRUG DOSE OMISSION 335 0.0020
871 EMOTIONAL DISTRESS 245 0.0020
872 NIGHTMARE 70 0.0020
873 BRONCHITIS 149 0.0020
874 DRY MOUTH 163 0.0020
875 DYSPEPSIA 197 0.0020
876 RIB FRACTURE 41 0.0020
877 FEBRILE NEUTROPENIA 132 0.0020
878 FATIGUE 1519 0.0019
879 WHEEZING 115 0.0019
880 RECTAL HAEMORRHAGE 83 0.0019
881 INCORRECT DOSE ADMINISTERED 441 0.0019
882 CHILLS 220 0.0019
883 ORAL PAIN 42 0.0019
884 NEOPLASM PROGRESSION 65 0.0019
885 FEELING ABNORMAL 445 0.0019
886 CEREBRAL HAEMORRHAGE 66 0.0018
887 DYSPNOEA EXERTIONAL 69 0.0018
888 NIGHT SWEATS 59 0.0018
889 HYPERKALAEMIA 62 0.0018
890 PREMATURE BABY 53 0.0018
891 VERTIGO 107 0.0018
892 INTENTIONAL DOSE OMISSION 50 0.0018
893 CONTUSION 165 0.0017
894 ANHEDONIA 45 0.0017
895 FEMUR FRACTURE 53 0.0017
896 NASOPHARYNGITIS 312 0.0017
897 GASTRIC DISORDER 58 0.0017
898 DISCOMFORT 103 0.0017
899 BLOOD GLUCOSE DECREASED 81 0.0017
900 NAUSEA 1321 0.0017
901 NEUROPATHY PERIPHERAL 158 0.0017
902 EXTRA DOSE ADMINISTERED 66 0.0016
903 LIMB INJURY 44 0.0016
904 HAEMORRHAGE 168 0.0016
905 ACCIDENTAL EXPOSURE TO PRODUCT 162 0.0016
906 MYALGIA 265 0.0016
907 LIMB DISCOMFORT 48 0.0015
908 VISION BLURRED 211 0.0015
909 ABDOMINAL PAIN UPPER 313 0.0015
910 DRUG EFFECT INCOMPLETE 55 0.0015
911 CRYING 55 0.0015
912 DYSPHONIA 88 0.0015
913 ARTHROPATHY 83 0.0015
914 OSTEOPOROSIS 61 0.0015
915 DEVICE ISSUE 128 0.0014
916 INTENTIONAL PRODUCT USE ISSUE 125 0.0014
917 EXPOSURE DURING PREGNANCY 88 0.0014
918 ABDOMINAL DISCOMFORT 237 0.0014
919 MUSCLE SPASMS 253 0.0014
920 INTERSTITIAL LUNG DISEASE 66 0.0014
921 THERAPEUTIC PRODUCT EFFECT DECREASED 61 0.0014
922 PLASMA CELL MYELOMA 53 0.0014
923 ABORTION SPONTANEOUS 54 0.0013
924 OSTEOARTHRITIS 57 0.0013
925 FLATULENCE 76 0.0013
926 PRODUCT SUBSTITUTION ISSUE 76 0.0013
927 ANGIOEDEMA 58 0.0013
928 BACK PAIN 304 0.0013
929 LACTIC ACIDOSIS 42 0.0013
930 NEPHROLITHIASIS 59 0.0013
931 VISUAL IMPAIRMENT 158 0.0013
932 UNDERDOSE 91 0.0012
933 DISEASE PROGRESSION 146 0.0012
934 FUNGAL INFECTION 41 0.0012
935 SWELLING FACE 80 0.0012
936 MULTIPLE SCLEROSIS 57 0.0012
937 NECK PAIN 66 0.0012
938 HERPES ZOSTER 67 0.0012
939 RHINORRHOEA 74 0.0011
940 THROMBOSIS 91 0.0011
941 ECZEMA 59 0.0011
942 FEELING HOT 69 0.0011
943 SKIN IRRITATION 51 0.0011
944 VAGINAL HAEMORRHAGE 48 0.0011
945 HEADACHE 672 0.0011
946 NERVOUSNESS 55 0.0011
947 DRUG EFFECT DECREASED 56 0.0010
948 DEVICE BREAKAGE 42 0.0010
949 PAIN 630 0.0010
950 PAIN IN EXTREMITY 297 0.0010
951 SKIN DISCOLOURATION 46 0.0010
952 DEVICE LEAKAGE 43 0.0010
953 CATARACT 59 0.0010
954 HYPOACUSIS 42 0.0010
955 PERIPHERAL SWELLING 150 0.0010
956 PARAESTHESIA 151 0.0010
957 FLUID RETENTION 48 0.0009
958 HYPERSENSITIVITY 175 0.0009
959 HYPOAESTHESIA 139 0.0009
960 NASAL CONGESTION 54 0.0009
961 MIGRAINE 85 0.0009
962 RASH 370 0.0008
963 MUSCULOSKELETAL PAIN 44 0.0008
964 ARTHRITIS 65 0.0008
965 HAEMATOCHEZIA 44 0.0008
966 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 158 0.0008
967 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 54 0.0008
968 ALOPECIA 141 0.0007
969 BLISTER 40 0.0007
970 FLUSHING 72 0.0007
971 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 124 0.0007
972 ARTHRALGIA 282 0.0007
973 EPISTAXIS 50 0.0007
974 DEVICE DIFFICULT TO USE 43 0.0006
975 DRUG DEPENDENCE 104 0.0006
976 BURNING SENSATION 44 0.0006
977 ACNE 47 0.0006
978 PROSTATE CANCER 49 0.0006
979 SWELLING 56 0.0006
980 ERYTHEMA 120 0.0006
981 HOT FLUSH 43 0.0006
982 SKIN EXFOLIATION 46 0.0005
983 PSORIASIS 70 0.0005
984 SINUSITIS 52 0.0005
985 JOINT SWELLING 60 0.0005
986 PRURITUS 138 0.0004
987 DRY SKIN 47 0.0004
988 URTICARIA 43 0.0003
989 INJECTION SITE PAIN 55 0.0002